Pharmacological Treatment of ADHD

Pharmacological Treatment of ADHD

Prateek Yadav
Copyright: © 2021 |Pages: 14
ISBN13: 9781799854951|ISBN10: 1799854957|EISBN13: 9781799854968
DOI: 10.4018/978-1-7998-5495-1.ch008
Cite Chapter Cite Chapter

MLA

Yadav, Prateek. "Pharmacological Treatment of ADHD." New Developments in Diagnosing, Assessing, and Treating ADHD, edited by Rejani Thudalikunnil Gopalan, IGI Global, 2021, pp. 132-145. https://doi.org/10.4018/978-1-7998-5495-1.ch008

APA

Yadav, P. (2021). Pharmacological Treatment of ADHD. In R. Gopalan (Ed.), New Developments in Diagnosing, Assessing, and Treating ADHD (pp. 132-145). IGI Global. https://doi.org/10.4018/978-1-7998-5495-1.ch008

Chicago

Yadav, Prateek. "Pharmacological Treatment of ADHD." In New Developments in Diagnosing, Assessing, and Treating ADHD, edited by Rejani Thudalikunnil Gopalan, 132-145. Hershey, PA: IGI Global, 2021. https://doi.org/10.4018/978-1-7998-5495-1.ch008

Export Reference

Mendeley
Favorite

Abstract

The pharmacological treatment for ADHD has been researched well and we have efficacious drugs. Drugs are the mainstay of treatment particularly for over 6 years of age. There are two broad classes of drugs that are used in the treatment, psychostimulants and non-stimulants. Transcranial current stimulation and neurofeedback are other mechanisms that have been tried. There are various formulations and doses available for each and only certain drugs are available in India. The various guidelines broadly put stimulant Methylphenidate as the first choice and recommend early shift to a longer acting formulation. Treatment, various comorbidities, and side-effects of these drugs have to be kept in mind and dealt accordingly. Further psychosocial treatments should be used concurrently to improve the outcome.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.